Sustainability

Simtra BioPharma Solutions is a premier diversified contract development and manufacturing organization (CDMO). Our footprint is global, matching our clients’ needs, with operations spanning two state-of-the-art facilities in the United States and Germany. We provide our customers with 65+ years of combined experience inherited from Baxter Pharmaceutical Solutions LLC and Baxter Oncology GmbH.

Established as standalone entity in 2023, we are at the start of a transformative journey, with the opportunity to build out a thoughtful program built for our business, people and communities. Sustainability has been top of mind in guiding the way we do business and will be critical in how we increase our footprint going forward. We are committed to leveraging our long-standing operational practices with a new lens on managing our environmental impact, ways that we can further benefit our communities, and bolster our governance practices.

We are fortified by strategic backing from Warburg Pincus and Advent International who will provide valuable input into our overall Sustainability strategy. Both pioneering firms are active members of Principles for Responsible Investment (PRI) and Sustainable Markets Initiative.

Our Sustainability commitments are led by a diverse group of senior executive leaders who span Regulatory & Quality, Human Resources, Legal, Risk & Integrity, Marketing, and Operations. The Steering Committee was established soon after the company’s formation in December 2023 both to support ongoing endeavors and to pioneer long-term strategies.